S&P’s revises outlook for Israel’s Teva Pharmaceutical Industries to negative

S&P’s revises outlook for Israel’s Teva Pharmaceutical Industries to negative
2.5 5

Post new comment

The content of this field is kept private and will not be shown publicly.